235 related articles for article (PubMed ID: 11933754)
21. Heparin-induced thrombocytopenia: cross-reactivity between standard heparin, low molecular weight heparin, dalteparin (Fragmin) and heparinoid, danaparoid (Orgaran).
Ramakrishna R; Manoharan A; Kwan YL; Kyle PW
Br J Haematol; 1995 Nov; 91(3):736-8. PubMed ID: 8555084
[TBL] [Abstract][Full Text] [Related]
22. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight.
Grims RH; Weger W; Reiter H; Arbab E; Kränke B; Aberer W
Br J Dermatol; 2007 Sep; 157(3):514-7. PubMed ID: 17573880
[TBL] [Abstract][Full Text] [Related]
23. Arthus reaction to lepirudin, a new recombinant hirudin, and delayed-type hypersensitivity to several heparins and heparinoids, with tolerance to its intravenous administration.
Jappe U; Reinhold D; Bonnekoh B
Contact Dermatitis; 2002 Jan; 46(1):29-32. PubMed ID: 11918584
[TBL] [Abstract][Full Text] [Related]
24. Heparin-induced thrombocytopenia: pathophysiology and management.
Mureebe L; Silver D
Vasc Endovascular Surg; 2002; 36(3):163-70. PubMed ID: 12075381
[TBL] [Abstract][Full Text] [Related]
25. Eczematous plaques related to unfractionated and low-molecular-weight heparin in pregnancy: cross-reaction with danaparoid sodium.
Blickstein D; Hod M; Bar J
Blood Coagul Fibrinolysis; 2003 Dec; 14(8):765-8. PubMed ID: 14614358
[TBL] [Abstract][Full Text] [Related]
26. Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.
Lubenow N; Greinacher A
J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():47-57. PubMed ID: 11155194
[No Abstract] [Full Text] [Related]
27. [Successful therapy of heparin-associated thrombocytopenia with a low sulfated heparinoid].
Herzog S; Rath W; Kuhn W
Geburtshilfe Frauenheilkd; 1995 Mar; 55(3):164-6. PubMed ID: 7665065
[TBL] [Abstract][Full Text] [Related]
28. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides.
Ludwig RJ; Schindewolf M; Alban S; Kaufmann R; Lindhoff-Last E; Boehncke WH
Thromb Haemost; 2005 Dec; 94(6):1265-9. PubMed ID: 16411404
[TBL] [Abstract][Full Text] [Related]
29. Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractionated and low-molecular-weight heparins: tolerance of a new recombinant hirudin.
Koch P; Münssinger T; Rupp-John C; Uhl K
J Am Acad Dermatol; 2000 Apr; 42(4):612-9. PubMed ID: 10727306
[TBL] [Abstract][Full Text] [Related]
30. Heparin-induced thrombocytopenia and its treatment.
Warkentin TE
J Thromb Thrombolysis; 2000 Jun; 9 Suppl 1():S29-35. PubMed ID: 10859582
[No Abstract] [Full Text] [Related]
31. In vitro cross-reactivity of danaparoid sodium in patients with heparin-induced thrombocytopenia type II undergoing cardiovascular surgery.
Koster A; Meyer O; Hausmann H; Kuppe H; Hetzer R; Mertzlufft F
J Clin Anesth; 2000 Jun; 12(4):324-7. PubMed ID: 10960207
[TBL] [Abstract][Full Text] [Related]
32. [Heparin-induced thrombocytopenia].
Depasse F; Samama MM
Ann Biol Clin (Paris); 2000; 58(3):317-26. PubMed ID: 10846236
[TBL] [Abstract][Full Text] [Related]
33. Management of allergy to heparins in postoperative care: subcutaneous allergy and intravenous tolerance.
Seitz CS; Brocker EB; Trautmann A
Dermatol Online J; 2008 Sep; 14(9):4. PubMed ID: 19061586
[TBL] [Abstract][Full Text] [Related]
34. Thromboembolic complications in a patient with heparin-induced thrombocytopenia (HIT) showing cross-reactivity to a low molecular weight heparin-treatment with Org 10172 (Lomoparan).
Muhm M; Claeys L; Huk I; Koppensteiner R; Kyrle PA; Minar E; Stümpflen A; Ehringer H; Polterauer P
Wien Klin Wochenschr; 1997 Feb; 109(4):128-31. PubMed ID: 9076930
[TBL] [Abstract][Full Text] [Related]
35. [Delayed intracutaneous test reaction in heparin intolerance].
Wurpts G; Merk HF
Hautarzt; 2007 May; 58(5):394-6. PubMed ID: 17450341
[No Abstract] [Full Text] [Related]
36. [Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
Chirurg; 1998 Nov; 69(11 Suppl Massnahme):1-4. PubMed ID: 9853175
[No Abstract] [Full Text] [Related]
37. Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans.
Ludwig RJ; Beier C; Lindhoff-Last E; Kaufmann R; Boehncke WH
Contact Dermatitis; 2003 Sep; 49(3):158-9. PubMed ID: 14678213
[No Abstract] [Full Text] [Related]
38. [Current status of anticoagulants].
Oger E; Mottier D
Presse Med; 2000 May 27-Jun 3; 29(19):1079-82. PubMed ID: 10874921
[TBL] [Abstract][Full Text] [Related]
39. Delayed hypersensitivity skin reaction to enoxaparin.
Méndez J; de la Fuente R; Stolle R; Vega JM; Sanchís ME; Armentia A; Sánchez P; Fernández A
Allergy; 1996 Nov; 51(11):853-4. PubMed ID: 8947349
[No Abstract] [Full Text] [Related]
40. Platelet aggregation in response to four low molecular weight heparins and the heparinoid ORG 10172 in patients with heparin-induced thrombocytopenia.
Keeling DM; Richards EM; Baglin TP
Br J Haematol; 1994 Feb; 86(2):425-6. PubMed ID: 7515270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]